Nuvilex, Inc. Moves
Nuvilex, Inc. Moves Closer to "Bio-Artificial Pancreas" Diabetes Treatment With License for Insulin-Producing Cells
October 21, 2014 09:00 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwired - October 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has carefully mapped out its plan to develop a diabetes treatment using the Cell-in-a-Box® platform technology. It started...
Learning about the new technology available to children with diabetes
New center at Kosair Children's Hospital will help transform lives of children with diabetes
November 14, 2013 16:01 ET | Norton Healthcare
LOUISVILLE, KY., Nov. 14, 2013 (GLOBE NEWSWIRE) -- The Wendy L. Novak Diabetes Care Center at Kosair Children's Hospital has opened, offering children with Type 1 diabetes access to advanced treatment...
PositiveID Corporati
PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas
March 05, 2012 08:00 ET | PositiveID Corporation
DELRAY BEACH, Fla., March 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has...
New Diabetes Study by Cutting Edge Information Examines Drugs, Classes, and Market Leaders
January 06, 2010 09:18 ET | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - January 6, 2010) - Cutting Edge Information (CEI) announces the release of its newest diabetes market forecast...